Comparison of six probiotic products containing Saccharomyces boulardii;Comparação de seis produtos probióticos contendo Saccharomyces boulardii

Revista Brasileira de Medicina

Volumn 62, Issue 4, 2005, Pages 151-155

  Dos Santos Martins, Flaviano ^a   Neves, Maria José ^b   Rosa, Carlos Augusto ^a   Drummond Nardi, Regina Maria ^a   Penna, Francisco José ^a   Nicoli, Jacques Robert ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO DE DESENVOLVIMENTO DA TECNOLOGIA NUCLEAR   (Brazil)

Author keywords

Probiotic; Reactivation; Saccharomyces boulardii

Indexed keywords

FLOMICIN; FLORATIL; FLORAZIN; FLORENT; LACTIPAN; PROBIOTIC AGENT; REPOFLOR; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; FUNGUS GROWTH; NONHUMAN; SACCHAROMYCES BOULARDII; YEAST CELL;

EID: 20444489203     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. a ed. Rio de Janeiro: MEDSI Editora Médica e Científica Ltda; 2000. p. 1905-19.
2. Nicoli JR, Vieira LQ. Microbiota gastrointestinal normal na doença e na saúde. In: Castro LP, Coelho LGV, editores. Gastroenterologia. Rio de Janeiro: MEDSI Editora Médica e Científica Ltda; 2004. p. 1037-47.
3. Czerucka D, Rampal P. Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 2002; 4:733-9.
4. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12:221-38.
5. 20 stimulates the phagocytic system of germfree mice. Braz J Med Biol Res 1998; 31:1565-73.
6. Rodrigues ACP, Cara DC, Fretez SHGG, Cunha FQ, Vieira EC, Nicoli JR et al. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000; 89:404-14.
7. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA1 binds to human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-9.
8. Brandão RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJM, et al. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 1998; 64:564-8.
9. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretaguoge-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 1994; 106:65-72.
10. Elmer GW, Surawicz CM, Mcfarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J Amer Med Assoc 1996; 275:870-6.
11. Silva AM, Bambirra EA, Oliveira AL, Souza PP, Gomes DA, Nicoli JR. Protective effect of bifidus milk on the experimental infection with Salmonella typhimurium in conventional and gnotobiotic mice. J Appl Microbiol 1999; 86:1-336.
12. Rodrigues ACP, Nardi RM, Bambirra EA, Vieira EC, Nicoli JR. Protective effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in gnotoxenic mice. J Appl Bacteriol 1996; 81:251-6.
13. Barros Lopes M, Soden A, Henschke PA, Landgridge P. PCR differentiation of commercial yeast strains using intron splice primers. Appl Environ Microbiol 1996; 62:4514-20.
14. Magalhães MF. Tempo de trânsito colônico. In: Castro LP, Coelho LGV, editores. Gastroenterologia. Rio de Janeiro: MEDSI Editora Médica e Científica Ltda.; 2004. p. 1445-9.